Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer
Completed · Phase 2
Conditions studied: Prostate Cancer
In brief
RATIONALE: Androgens can stimulate the growth of prostate cancer cells. Hormone therapy using leuprolide and flutamide may fight prostate cancer by reducing the production of androgens. Combining radiation therapy with hormone therapy may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of hormone therapy plus radiation therapy in treating patients with prostate cancer.
Key facts
- Study ID
- NCT00003124
- Run by
- Herbert Irving Comprehensive Cancer Center
- People needed
- 105
- Starts
- 1997-05-01
- Expected to finish
- 2007-01-01
- Last updated by the study team
- 2014-01-06
Who can join
Age: any. Sex: male. Healthy volunteers: not accepted.
Where it is running
- Herbert Irving Comprehensive Cancer Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.